Cargando…
Endorsement of COVID-19 related misinformation among cancer survivors
OBJECTIVES: To determine whether cancer survivors currently in treatment are more or less likely to endorse COVID-19 related misinformation compared to their counterparts no longer in treatment and those without a cancer history. METHODS: We conducted a Qualtrics survey among 897 adults to determine...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139169/ https://www.ncbi.nlm.nih.gov/pubmed/34030928 http://dx.doi.org/10.1016/j.pec.2021.05.026 |
_version_ | 1783695950782398464 |
---|---|
author | Guidry, Jeanine P.D. Carlyle, Kellie E. Miller, Carrie A. Ksinan, Albert J. Winn, Robert Sheppard, Vanessa B. Fuemmeler, Bernard F. |
author_facet | Guidry, Jeanine P.D. Carlyle, Kellie E. Miller, Carrie A. Ksinan, Albert J. Winn, Robert Sheppard, Vanessa B. Fuemmeler, Bernard F. |
author_sort | Guidry, Jeanine P.D. |
collection | PubMed |
description | OBJECTIVES: To determine whether cancer survivors currently in treatment are more or less likely to endorse COVID-19 related misinformation compared to their counterparts no longer in treatment and those without a cancer history. METHODS: We conducted a Qualtrics survey among 897 adults to determine differences in endorsement of COVID-19 misinformation among cancer survivors in active treatment, cancer survivors no longer in treatment, and a control group with no cancer history. RESULTS: Cancer survivors currently undergoing treatment were more likely to believe misinformation related to COVID-19 than those without a cancer history. Least likely to endorse COVID-19 misinformation were cancer survivor no longer in treatment. CONCLUSION: These results alert healthcare professionals to overall high levels of endorsement of COVID-19 misinformation among cancer survivors on active treatment. Oncologists and other providers working with patients undergoing treatment for cancer should be particularly mindful of the potential elevated beliefs in misinformation among this group. PRACTICAL IMPLICATIONS: Since patients undergoing cancer treatment seem to be particularly vulnerable to COVID-19 misinformation, oncologists and other healthcare providers working with this patient population should help address patients’ concerns about the pandemic and how it relates to their course of treatment. |
format | Online Article Text |
id | pubmed-8139169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81391692021-05-21 Endorsement of COVID-19 related misinformation among cancer survivors Guidry, Jeanine P.D. Carlyle, Kellie E. Miller, Carrie A. Ksinan, Albert J. Winn, Robert Sheppard, Vanessa B. Fuemmeler, Bernard F. Patient Educ Couns Short Communication OBJECTIVES: To determine whether cancer survivors currently in treatment are more or less likely to endorse COVID-19 related misinformation compared to their counterparts no longer in treatment and those without a cancer history. METHODS: We conducted a Qualtrics survey among 897 adults to determine differences in endorsement of COVID-19 misinformation among cancer survivors in active treatment, cancer survivors no longer in treatment, and a control group with no cancer history. RESULTS: Cancer survivors currently undergoing treatment were more likely to believe misinformation related to COVID-19 than those without a cancer history. Least likely to endorse COVID-19 misinformation were cancer survivor no longer in treatment. CONCLUSION: These results alert healthcare professionals to overall high levels of endorsement of COVID-19 misinformation among cancer survivors on active treatment. Oncologists and other providers working with patients undergoing treatment for cancer should be particularly mindful of the potential elevated beliefs in misinformation among this group. PRACTICAL IMPLICATIONS: Since patients undergoing cancer treatment seem to be particularly vulnerable to COVID-19 misinformation, oncologists and other healthcare providers working with this patient population should help address patients’ concerns about the pandemic and how it relates to their course of treatment. Elsevier B.V. 2022-02 2021-05-21 /pmc/articles/PMC8139169/ /pubmed/34030928 http://dx.doi.org/10.1016/j.pec.2021.05.026 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Guidry, Jeanine P.D. Carlyle, Kellie E. Miller, Carrie A. Ksinan, Albert J. Winn, Robert Sheppard, Vanessa B. Fuemmeler, Bernard F. Endorsement of COVID-19 related misinformation among cancer survivors |
title | Endorsement of COVID-19 related misinformation among cancer survivors |
title_full | Endorsement of COVID-19 related misinformation among cancer survivors |
title_fullStr | Endorsement of COVID-19 related misinformation among cancer survivors |
title_full_unstemmed | Endorsement of COVID-19 related misinformation among cancer survivors |
title_short | Endorsement of COVID-19 related misinformation among cancer survivors |
title_sort | endorsement of covid-19 related misinformation among cancer survivors |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139169/ https://www.ncbi.nlm.nih.gov/pubmed/34030928 http://dx.doi.org/10.1016/j.pec.2021.05.026 |
work_keys_str_mv | AT guidryjeaninepd endorsementofcovid19relatedmisinformationamongcancersurvivors AT carlylekelliee endorsementofcovid19relatedmisinformationamongcancersurvivors AT millercarriea endorsementofcovid19relatedmisinformationamongcancersurvivors AT ksinanalbertj endorsementofcovid19relatedmisinformationamongcancersurvivors AT winnrobert endorsementofcovid19relatedmisinformationamongcancersurvivors AT sheppardvanessab endorsementofcovid19relatedmisinformationamongcancersurvivors AT fuemmelerbernardf endorsementofcovid19relatedmisinformationamongcancersurvivors |